Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-2.55	123.09	126.31
Graham Fair Price	28.29	10.08	7.86
PEG	-62.76	0.34	-0.92
Price/Book	1.74	9.98	9.81
Price/Cash Flow	1093.28	1668.90	139.86
Prices/Earnings	-35.63	20.75	32.24
Price/Sales	-0.49	23.34	23.45
Price/FCF	1093.28	1668.90	139.86
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.14	0.63	0.57
Operating Margin	-9.57	0.19	0.21
ROA	58.29	0.03	0.02
ROE	0.08	0.12	58.05
ROIC	0.03	0.03	-3.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.05	-75.48
Dividends QOQ	0.95	-0.97	2.47
EBIT QOQ	-0.30	-0.06	80.95
EPS QOQ	-0.35	0.61	72.87
FCF QOQ	-0.54	-0.91	-70.60
Revenue QOQ	-0.09	0.04	-54.99
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	85.92	105.43	22.70
Days Sales Outstanding (DSO)	28.29	33.80	19.49
Inventory Turnover	1.05	0.85	-18.50
Debt/Capitalization	0.62	0.62	-0.27
Quick Ratio	0.72	0.75	3.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.01	6.13	2.05
Cash	3.16	3.93	24.03
Capex	-0.20	-0.09	56.45
Free Cash Flow	0.42	0.04	-91.30
Revenue	2.51	2.62	4.33
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.13	1.04	-8.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.39	13.36	-7.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating